The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome

Clinical trial NCT02506231 · UNKNOWN

Trial details

NCT number: NCT02506231
Sponsor: Rabin Medical Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Graft vs Host Disease Allogeneic Hematopoietic Cell Transplantation Mucositis

Start date: 2015-10-01
Primary completion: 2017-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.